Vedanta board approves funds fundraise of ₹3,000 crore via NCDs; share jumps 5%

Vedanta share price jumped over 5% in intra-day deals on Wednesday, February 25 after its board approved fundraise of 3,000 crore via NCDs

Vedanta on Wednesday, February 25, 2026, said its board-constituted Committee of Directors has approved the issuance of unsecured, rated, listed and redeemable non-convertible debentures (NCDs) aggregating up to 3,000 crore through a private placement.

“..we hereby inform that the duly authorized Committee of Directors at its meeting held today i.e., Wednesday, February 25, 2026, has considered and approved the issuance of Unsecured, Rated, Listed, Redeemable, Non-Convertible Debentures (“NCDs”) on a private placement basis (upto 3,00,000 nos. of face value 1,00,000/- each) aggregating upto 3,000 Crores,” it said in a regulatory filing.

In a regulatory filing to stock exchanges, the company said the approval was granted at the committee meeting held earlier in the day. The proposed issuance will comprise up to 3,00,000 NCDs, each with a face value of 1,00,000, taking the total issue size to 3,000 crore.

According to the disclosure, the bonds will be issued on a private placement basis.

Vedanta share performance

The stock rose 5.3% to its day’s high of 732 on BSE. It is just 5% away from its 52-week high of 770, hit in January 2026. Meanwhile, it has rallied 102%, touched in April 2025.

The stock has delivered strong gains across timeframes, rising 77% over the past one year, 60% in the last six months, 43% over three months and nearly 6% in the past month. Over a five-year period, it has turned into a multibagger, rallying 247%.

BofA upgrades Vedanta

BofA Securities has upgraded the stock to a “Buy” from “Neutral” and raised its target price sharply to 840 from 480, implying an upside of about 75%.

The global brokerage pointed to a more favourable outlook for aluminium prices, continued support from silver prices and an attractive dividend yield estimated at over 6% for FY27. It also noted that meaningful deleveraging at the parent level lowers the risk of any hike in brand-fee rates or inter-corporate loans.

BofA has revised up its EBITDA estimates for Vedanta for FY26E–FY28E by 16–21%, factoring in higher aluminium price assumptions, a higher fair valuation for Hindustan Zinc, depreciation in the USD-INR exchange rate and a reduction in the holding-company discount to 5% from 15% earlier.

Vedanta Q3 Results

Vedanta posted a strong performance in the third quarter, reporting a 61% year-on-year increase in consolidated profit at 5,710 crore, while revenue rose 19% to 45,899 crore. EBITDA surged 34% year-on-year and 31% sequentially to a record 15,171 crore, with margins expanding to 41%, aided by higher metal prices, stronger premiums, better volumes and cost efficiencies.

The aluminium segment delivered a standout operational performance, with alumina production jumping 57% year-on-year to a record 794 kilo tonnes. Aluminium cost of production declined 11% year-on-year to $1,674 per tonne, supporting margin expansion. Zinc India and international zinc operations also reported robust growth, driven by favourable commodity prices and improved volumes.

Improved operating performance translated into stronger capital efficiency, with return on capital employed rising to 27%, nearly 300 basis points higher than a year earlier.

Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.

Latest

HCLTech, TCS, Infosys: Why are IT stocks falling again?

Fresh pressure on IT shares as demand concerns and foreign selling unsettle investors

Dr Reddy’s jumps nearly 7% as Sensex falls: Why is the pharma stock rising?

Shares of Dr Reddy’s Laboratories surged sharply on Thursday, bucking a weak broader market and emerging as one of the top gainers on the Nifty 50.

Sensex tumbles 650 points: Why is the stock market falling?

Stock markets remained sharply lower in early trade on Thursday as crude oil above $100, global uncertainty and broad-based selling in financial and IT stocks w

Sensex, Nifty sink as crude oil prices reach $100; IndiGo down 2%

The S&P BSE Sensex was down by 625.09 points to 77,891.40, while the NSE Nifty50 lost 173.90 points to 24,204.20 as of 9:26 am. 

Groww shares hit 52-week high: What’s driving the rally and should you buy now?

Groww shares soar to new heights, but brokerages offer mixed advice

Topics

Selfless Virat Kohli praises Devdutt Padikkal as real hero of RCB’s win over GT

Virat Kohli credited Devdutt Padikkal after Royal Challengers Bengaluru chased down 206 against Gujarat Titans. Their partnership shaped the chase and kept RCB

UK mother, 56, dies at assisted dying clinic in Switzerland after son’s death

A 56-year-old woman from the UK has died at an assisted dying clinic in Switzerland, according to news report. She had earlier spoken about struggling with grie

Michael Box Office Collection: Jaafar Jackson film breaks records with $12.6M US previews despite poor reviews

Lionsgate's Michael Jackson biopic 'Michael' is heading for a record-breaking opening weekend with $12.6 million in US previews and $18.5 million internationall

Grieving UK mother ends life at Swiss clinic after paying £10,000

A grieving British mother, Wendy Duffy, died by assisted suicide in Switzerland after losing her son, sparking debate over suicide tourism, legality, and ethica

Khal Nayak is back: Sanjay Dutt unveils teaser, revives iconic role in new Jio Studios film

Sanjay Dutt and Aksha Kamboj have acquired rights to the 1993 film Khal Nayak, with Jio Studios set to produce a new project. The move signals a revival of the

AI smart glasses will help visually impaired runners take on the London Marathon

AI smart glasses will help visually impaired runners take on the London Marathon

Iran’s FM Abbas Araghchi to visit Pakistan, confirms Iranian state media

The US logistics and security team have already reached Islamabad, Reuters reported citing government sources.

Explained: Why Iran is not ready to compromise with US despite pressure

US-Iran conflict: Tensions between Washington and Tehran remain on edge as diplomatic efforts to secure a truce show no signs of progress. Earlier this week,
spot_img

Related Articles

Popular Categories

spot_imgspot_img